Document is current
Any future updates will be listed below
-
Authors
Thoms, Julie A. I. https://orcid.org/0000-0002-4876-7230
Yan, Feng https://orcid.org/0000-0002-8848-1739
Hampton, Henry R. https://orcid.org/0000-0002-1121-8764
Davidson, Sarah
Joshi, Swapna
Saw, Jesslyn
Sarowar, Chowdhury H.
Lim, Xin Ying
Nunez, Andrea C.
Kakadia, Purvi M.
Bhuyan, Golam Sarower
Zou, Xiaoheng
Nguyen, Mary
Ghodousi, Elaheh S.
Koch, Forrest C.
Vafaee, Fatemeh https://orcid.org/0000-0002-7521-2417
Thompson, I. Richard https://orcid.org/0000-0002-9554-550X
Karimi, Mohammad M. https://orcid.org/0000-0001-5017-1252
Pickford, Russell
Raftery, Mark J.
Hough, Sally
Buckland, Griselda
Bailey, Michelle
Ghodke, Yuvaraj https://orcid.org/0009-0003-4479-5888
Absar, Noorul
Vaughan, Lachlin
Pasalic, Leonardo
Fong, Chun Y.
Kenealy, Melita
Hiwase, Devendra K. https://orcid.org/0000-0002-6666-3056
Stoddart, Rohanna I.
Mohammed, Soma
Lee, Linda
Passam, Freda H.
Larsen, Stephen R.
Spring, Kevin J. https://orcid.org/0000-0003-0601-924X
Skarratt, Kristen K. https://orcid.org/0000-0003-4971-2773
Rebeiro, Patricia
Presgrave, Peter
Stevenson, William S.
Ling, Silvia
Tiley, Campbell
Fuller, Stephen J. https://orcid.org/0000-0003-4637-7391
Roncolato, Fernando https://orcid.org/0009-0007-9955-5928
Enjeti, Anoop K.
Hoenemann, Dirk
Lemech, Charlotte
Jolly, Christopher J.
Bohlander, Stefan K. https://orcid.org/0000-0002-2202-9088
Curtis, David J. https://orcid.org/0000-0001-9497-0996
Wong, Jason W. H.
Unnikrishnan, Ashwin https://orcid.org/0000-0001-5168-8755
Hertzberg, Mark
Olivier, Jake https://orcid.org/0000-0002-3144-4507
Polizzotto, Mark N.
Pimanda, John E. https://orcid.org/0000-0002-0509-8962
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (RG170246, RG211412)
Anthony Rothe Memorial Trust (RG182042, RG202657, RG213236)
Celgene (RG172029)
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 1 May 2025
First Online: 13 May 2025
Competing interests
: F.V. is affiliated with OmniOmics.AI Pty Ltd. C.F. is an advisory board member at Amgen, AbbVie, Adaptive Biotech, BeiGene, Pfizer, Otsuka, and Jazz, a consultant at Novotech, and received speaker fees from Amgen, Pfizer, Servier, BMS, and Astella. D.H. has consultancy agreements with GlaxoSmithKline and Pharming Corp. M.H. is a consultant/advisory board member at Roche, Gilead, Otsuka, Janssen, Beigene, and Takeda. M.N.P. received research funding and/or provision of drug for clinical trials (to institution) from AstraZeneca, BRII Biosciences, Celgene/BMS, CSL Behring, Eli Lilly, Emergent Biosciences, Gilead Pharmaceuticals, GlaxoSmithKline, Grifols, Janssen/Johnson and Johnson, Takeda, ViiV Pharmaceuticals and has advisory roles with Celgene/BMS, Gilead Pharmaceuticals, and ViiV Pharmaceuticals. J.E.P. received research funding and/or provision of drug for clinical trials (to institution) from Celgene/BMS, Astex, Verastem Oncology and received honoraria from Abbvie as an advisory board member. The remaining authors declare no competing interests.
